0001144204-17-026071.txt : 20170510
0001144204-17-026071.hdr.sgml : 20170510
20170510163035
ACCESSION NUMBER: 0001144204-17-026071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170508
FILED AS OF DATE: 20170510
DATE AS OF CHANGE: 20170510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: China Biologic Products, Inc.
CENTRAL INDEX KEY: 0001369868
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 752308816
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18TH FL, JIALONG INTERNATIONALBUILDING
STREET 2: 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
CITY: BEIJING
STATE: F4
ZIP: 100125
BUSINESS PHONE: 86-10-6598-3111
MAIL ADDRESS:
STREET 1: 18TH FL, JIALONG INTERNATIONALBUILDING
STREET 2: 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
CITY: BEIJING
STATE: F4
ZIP: 100125
FORMER COMPANY:
FORMER CONFORMED NAME: GRC Holdings, Inc.
DATE OF NAME CHANGE: 20060721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liu Zhijing CBPO
CENTRAL INDEX KEY: 0001575517
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34566
FILM NUMBER: 17830745
MAIL ADDRESS:
STREET 1: 19 CHAOYANG PARK ROAD
STREET 2: 18/F, JIALONG INTERNATIONAL BUILDING
CITY: BEIJING
STATE: F4
ZIP: 100125
4
1
v466479_4.xml
OWNERSHIP DOCUMENT
X0306
4
2017-05-08
0
0001369868
China Biologic Products, Inc.
CBPO
0001575517
Liu Zhijing CBPO
18TH FLOOR, JIALONG INTERNATIONAL
BUILDING, 19 CHAOYANG PARK ROAD
BEIJING
F4
100125
CHINA
0
1
0
0
Corporate Vice President
Common Stock
2017-05-08
4
M
0
6358
9.85
A
10969
D
Common Stock
2017-05-08
4
S
0
6358
116.68
D
4611
D
Common Stock
2017-05-09
4
M
0
1142
9.85
A
5753
D
Common Stock
2017-05-09
4
S
0
1142
115.40
D
4611
D
Stock Option (right to buy)
9.85
2017-05-08
4
M
0
6358
D
2016-09-01
2022-08-31
Common Stock
6358
1142
D
Stock Option (right to buy)
9.85
2017-05-09
4
M
0
1142
D
2016-09-01
2022-08-31
Common Stock
1142
0
D
Represents 6,358 shares of common stock acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnote 7 below for further details on the relevant stock options.
Represents 6,358 shares of common stock sold on the open market at a weighted average price of $116.68 per share on May 8, 2017.
Represents 1,142 shares of common stock acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnote 7 below for further details on the relevant stock options.
Represents 1,142 shares of common stock sold on the open market at a weighted average price of $115.40 per share on May 9, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $116.62 to $116.95, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 5.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $115.20 to $115.65, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 6.
Represents previously reported stock options to purchase 15,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options were vested annually over a 4-year period in four equal portions, with the initial vesting date being September 1, 2013.
/s/ Liu Zhijing
2017-05-10